Weight-loss medications are walking into your practice whether you’re ready or not. As semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro) become routine prescriptions for patients pursuing weight management, their systemic effects may have crossed into your operatory, bringing new oral health challenges and sedation considerations you can’t ignore. This week, Dentistry 411 shares what you need to know about these weight loss medications and their effect on the oral cavity.
Dry Mouth, Reflux, and “Ozempic Teeth”
Semaglutides mimic GLP-1, slowing digestion and reducing appetite. The downside is reduced salivary flow and slowed gastric emptying, leading to dry mouth and increased acid reflux. Combined with nausea and occasional vomiting, these factors contribute to enamel erosion, dentinal hypersensitivity, and increased caries risk.
Patients on these medications may report altered taste and persistent halitosis. Slower digestion and reduced saliva allow oral bacteria to thrive, compounding periodontal inflammation risk. Watch for subtle signs of early erosion on palatal surfaces, cervical demineralization, and worsening xerostomia in these patients, especially if they’re on a high-protein, low-carb diet while medicated.
Anesthesia Red Flags
GLP-1 agonists delay gastric emptying, increasing regurgitation and aspiration risk under general anesthesia or deep sedation. Preoperative planning in these cases is essential. For daily dosing patients, consider holding the medication the day of the procedure. For weekly dosing, consider withholding for a week before surgery.
Evidence from the Canadian Journal of Anesthesia suggests a conservative approach: Hold semaglutide for at least three half-lives (about three weeks) before elective procedures requiring sedation to minimize aspiration risk. This is especially important for oral surgeons and sedation dentists who routinely manage airway risks.
Treatment Modifications Worth Implementing
- Saliva Support
Recommend remineralizing agents, sugar-free chewing gums, and customized fluoride therapies for patients showing dry mouth signs.
- Reflux Mitigation
Encourage upright positioning post meals and potential antacid use (coordinated with their physician) if reflux symptoms worsen oral erosion.
- Medical History Updates
Actively ask about GLP-1 medications during intake, noting dosage schedules to plan sedation safely.
- Caries Management
Increase caries risk assessment vigilance, and discuss diet and hygiene reinforcement.
- Pre-Sedation Planning
Collaborate with patients and medical providers to schedule medication holds and monitor fasting status before sedation procedures.
The number of patients on GLP-1 agonists will continue to rise as these medications gain popularity in weight management and diabetes care. These drugs are reshaping your patient population’s systemic profile and oral environment. Don’t be caught off guard. Stay ahead by building GLP-1 medication considerations into your routine assessments, hygiene protocols, and preoperative workflows.
Dentistry 411 will continue to track the science, the products, and the legal landscape so you don’t have to. Subscribe to stay ahead of the curve, cut through the marketing, and make smarter decisions in your dental practice.
SOURCES: Canadian Journal of Anesthesia, FDA, ASA, Oral Health Group
This content is intended for educational purposes only and does not substitute for clinical judgment. Treatment decisions should be based on individual patient needs, professional guidelines, and a comprehensive clinical evaluation.
